UPDATE : Monday, October 15, 2018
상단여백
Bio stocks listed under ‘tech exception policy’ perform better by Nam Doo-hyun 2018-10-15 12:27
Anticipation grows for Lenvima as new liver cancer drug by Nam Doo-hyun 2018-10-11 11:44
‘Korea publishes many biotech papers but rarely links them to biz’ by Nam Doo-hyun 2018-10-10 16:35
More biotech stocks come in top 20 on KOSDAQ by Nam Doo-hyun 2018-10-10 11:20
‘Medytox performance depends on Chinese regulations on peddlers’ by Nam Doo-hyun 2018-10-08 16:59
라인
Newly listed biotech firms perform poorly on KOSDAQ by Nam Doo-hyun 2018-10-04 13:09
‘Samsung C&T’s value to rise on BioLogics’ increased value’ by Nam Doo-hyun 2018-10-03 10:11
More doctoral degree holders wanted at biotech ventures by Nam Doo-hyun 2018-10-02 14:40
Which health agency had highest rise in female worker percentage? by Nam Doo-hyun 2018-10-01 13:38
Samil shares jump on anticipation of fatty liver treatment by Nam Doo-hyun 2018-09-28 14:21
라인
Genexine wins nod for immunotherapy trial in combo treatment by Nam Doo-hyun 2018-09-27 11:25
Korea’s drug exports continue to rise in August by Nam Doo-hyun 2018-09-20 14:23
‘Many Korean hospitals operating in China remain unlawful’ by Nam Doo-hyun 2018-09-20 14:22
Shares of newly listed biotech firms surge by Nam Doo-hyun 2018-09-19 18:30
‘If you can’t avoid healthcare regulation, enjoy it’ by Nam Doo-hyun 2018-09-19 14:43
라인
‘Smart hospitals’ to reduce repetitive nursing work by Nam Doo-hyun 2018-09-17 15:48
Nature Cell shares spike despite investment alert warning by Nam Doo-hyun 2018-09-14 16:08
Female workforce scarce in top 15 local pharmaceuticals by Nam Doo-hyun 2018-09-13 11:41
GC Cell shares spike on winning FDA nod for Immuncell-LC by Nam Doo-hyun 2018-09-12 16:05
‘Xgeva reduces risk of bone problems in solid tumor patients’ by Nam Doo-hyun 2018-09-12 12:23
여백
여백
여백
Back to Top